Shandong Pharmaceutical Glass Co., Ltd.SSE: 600529

(600529)"Shandong Pharmaceutical Glass Co., Ltd."Indicative Announcement on the Reply to the Review Inquiry Letter Regarding the Application Documents for the Private Placement of Shares and Updates of the Prospectus and Other Application Documents

· Issued by Shandong Pharmaceutical Glass Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600529 · · 1 page · Chinese

Summary by 6ix AI

Shandong Pharmaceutical Glass Co., Ltd. has issued an indicative announcement regarding its response to a review inquiry letter related to its application for a private placement of shares and updates to its prospectus and other application documents.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/600529shandong-pharmaceutical-glass-co-ltdindicative-announcement-on-the-reply-to-the-review-inquiry-letter-regarding-the-application-documents-for-the-private-placement-of-shares-and-updates-of-the-prospectus-and-other-application-documents

Release

Indicative Announcement on the Reply to the Review Inquiry Letter Regarding the Application Documents for the Private Placement of Shares and Updates of the Prospectus and Other Application Documents

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shandong Pharmaceutical Glass Co., Ltd. on 6ix

Story so far

Earlier from Shandong Pharmaceutical Glass

Later from Shandong Pharmaceutical Glass

All Shandong Pharmaceutical Glass news releases